DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?
DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice
Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Stocks Warren Buffett Owns More Than 10% of Right Now
In August, Warren Buffett's Berkshire Hathaway (NYSE: BRK-B) became the first non-tech U.S.
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market
DaVita HealthCare (DVA) closed the most recent trading day at $163.16, moving -0.65% from the previous trading session.
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, DaVita HealthCare (DVA) closed at $164.22, indicating a -0.59% shift from the previous trading day.
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN
Stocks making new highs tend to make even higher highs, particularly when positive earnings estimate revisions hit the tape. And that's precisely what these three companies have seen.
DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are Investors Undervaluing DaVita (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's What You Should Know
DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?
DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?
